LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34 | -48.5% | 30,937 | +7.4% | 0.00% | – |
| Q2 2023 | $66 | +15.8% | 28,815 | +23.9% | 0.00% | – |
| Q1 2023 | $57 | +29.5% | 23,255 | +1.7% | 0.00% | – |
| Q4 2022 | $44 | -99.9% | 22,866 | -5.1% | 0.00% | – |
| Q3 2022 | $58,000 | +123.1% | 24,096 | +94.4% | 0.00% | – |
| Q1 2022 | $26,000 | -39.5% | 12,393 | +13.7% | 0.00% | – |
| Q4 2021 | $43,000 | -52.2% | 10,901 | +4.0% | 0.00% | -100.0% |
| Q1 2018 | $90,000 | -44.1% | 10,479 | -35.6% | 0.00% | 0.0% |
| Q4 2017 | $161,000 | +73.1% | 16,261 | +151.4% | 0.00% | 0.0% |
| Q2 2016 | $93,000 | +55.0% | 6,469 | +29.2% | 0.00% | – |
| Q1 2016 | $60,000 | +17.6% | 5,006 | +30.9% | 0.00% | – |
| Q4 2015 | $51,000 | -7.3% | 3,824 | -25.0% | 0.00% | – |
| Q3 2015 | $55,000 | +323.1% | 5,096 | +220.9% | 0.00% | – |
| Q2 2015 | $13,000 | – | 1,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |